Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 91
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Nature ; 601(7891): 69-73, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34987213

RESUMEN

The 660-kilometre seismic discontinuity is the boundary between the Earth's lower mantle and transition zone and is commonly interpreted as being due to the dissociation of ringwoodite to bridgmanite plus ferropericlase (post-spinel transition)1-3. A distinct feature of the 660-kilometre discontinuity is its depression to 750 kilometres beneath subduction zones4-10. However, in situ X-ray diffraction studies using multi-anvil techniques have demonstrated negative but gentle Clapeyron slopes (that is,  the ratio between pressure and temperature changes) of the post-spinel transition that do not allow a significant depression11-13. On the other hand, conventional high-pressure experiments face difficulties in accurate phase identification due to inevitable pressure changes during heating and the persistent presence of metastable phases1,3. Here we determine the post-spinel and akimotoite-bridgmanite transition boundaries by multi-anvil experiments using in situ X-ray diffraction, with the boundaries strictly based on the definition of phase equilibrium. The post-spinel boundary has almost no temperature dependence, whereas the akimotoite-bridgmanite transition has a very steep negative boundary slope at temperatures lower than ambient mantle geotherms. The large depressions of the 660-kilometre discontinuity in cold subduction zones are thus interpreted as the akimotoite-bridgmanite transition. The steep negative boundary of the akimotoite-bridgmanite transition will cause slab stagnation (a stalling of the slab's descent) due to significant upward buoyancy14,15.

2.
Nature ; 599(7886): 605-610, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34819683

RESUMEN

Solids in nature can be generally classified into crystalline and non-crystalline states1-7, depending on whether long-range lattice periodicity is present in the material. The differentiation of the two states, however, could face fundamental challenges if the degree of long-range order in crystals is significantly reduced. Here we report a paracrystalline state of diamond that is distinct from either crystalline or amorphous diamond8-10. The paracrystalline diamond reported in this work, consisting of sub-nanometre-sized paracrystallites that possess a well-defined crystalline medium-range order up to a few atomic shells4,5,11-13, was synthesized in high-pressure high-temperature conditions (for example, 30 GPa and 1,600 K) employing face-centred cubic C60 as a precursor. The structural characteristics of the paracrystalline diamond were identified through a combination of X-ray diffraction, high-resolution transmission microscopy and advanced molecular dynamics simulation. The formation of paracrystalline diamond is a result of densely distributed nucleation sites developed in compressed C60 as well as pronounced second-nearest-neighbour short-range order in amorphous diamond due to strong sp3 bonding. The discovery of paracrystalline diamond adds an unusual diamond form to the enriched carbon family14-16, which exhibits distinguishing physical properties and can be furthered exploited to develop new materials. Furthermore, this work reveals the missing link in the length scale between amorphous and crystalline states across the structural landscape, having profound implications for recognizing complex structures arising from amorphous materials.

3.
Proc Natl Acad Sci U S A ; 119(44): e2211243119, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36279458

RESUMEN

Water transported by subducted oceanic plates changes mineral and rock properties at high pressures and temperatures, affecting the dynamics and evolution of the Earth's interior. Although geochemical observations imply that water should be stored in the lower mantle, the limited amounts of water incorporation in pyrolitic lower-mantle minerals suggest that water in the lower mantle may be stored in the basaltic fragments of subducted slabs. Here, we performed multianvil experiments to investigate the stability and water solubility of aluminous stishovite and CaCl2-structured silica, referred to as poststishovite, in the SiO2-Al2O3-H2O systems at 24 to 28 GPa and 1,000 to 2,000 °C, representing the pressure-temperature conditions of cold subducting slabs to hot upwelling plumes in the top lower mantle. The results indicate that both alumina and water contents in these silica minerals increase with increasing temperature under hydrous conditions due to the strong Al3+-H+ charge coupling substitution, resulting in the storage of water up to 1.1 wt %. The increase of water solubility in these hydrous aluminous silica phases at high temperatures is opposite of that of other nominally anhydrous minerals and of the stability of the hydrous minerals. This feature prevents the releasing of water from the subducting slabs and enhances the transport water into the deep lower mantle, allowing significant amounts of water storage in the high-temperature lower mantle and circulating water between the upper mantle and the lower mantle through subduction and plume upwelling. The shallower depths of midmantle seismic scatterers than expected from the pure SiO2 stishovite-poststishovite transition pressure support this scenario.

4.
Gan To Kagaku Ryoho ; 50(13): 1854-1856, 2023 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-38303230

RESUMEN

In recent years, bridge to surgery(BTS), in which surgery is performed after colorectal stenting for obstructive colorectal cancer, has gradually become popular, and laparoscopic surgery is also a treatment option. From January 2020 to December 2022, we retrospectively evaluated clinicopathological factors in 18 colorectal cancer cases who underwent radical resection after colorectal stenting. We found no difference in patient background, histopathological factors, primary anastomosis rate, stoma creation rate, operative time, postoperative complication rate and length of hospital stay between the laparoscopic surgery(L)and open surgery(O)groups. Blood loss was significantly lower in group L. In T4 patients, laparoscopic surgery after colorectal stenting can be safely performed, but conversion to open surgery may be necessary. Surgery after colorectal stenting should be performed based on preoperative accurate imaging and sufficient experience.


Asunto(s)
Neoplasias Colorrectales , Obstrucción Intestinal , Laparoscopía , Humanos , Neoplasias Colorrectales/cirugía , Neoplasias Colorrectales/complicaciones , Estudios Retrospectivos , Obstrucción Intestinal/etiología , Obstrucción Intestinal/cirugía , Resultado del Tratamiento , Stents/efectos adversos , Laparoscopía/efectos adversos
5.
J Synchrotron Radiat ; 29(Pt 2): 409-423, 2022 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-35254304

RESUMEN

Penetrating, high-energy synchrotron X-rays are in strong demand, particularly for high-pressure research in physics, chemistry and geosciences, and for materials engineering research under less extreme conditions. A new high-energy wiggler beamline P61 has been constructed to meet this need at PETRA III in Hamburg, Germany. The first part of the paper offers an overview of the beamline front-end components and beam characteristics. The second part describes the performance of the instrumentation and the latest developments at the P61B endstation. Particular attention is given to the unprecedented high-energy photon flux delivered by the ten wigglers of the PETRA III storage ring and the challenges faced in harnessing this amount of flux and heat load in the beam. Furthermore, the distinctiveness of the world's first six-ram Hall-type large-volume press, Aster-15, at a synchrotron facility is described for research with synchrotron X-rays. Additionally, detection schemes, experimental strategies and preliminary data acquired using energy-dispersive X-ray diffraction and radiography techniques are presented.

6.
J Biol Chem ; 294(44): 16034-16048, 2019 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-31506300

RESUMEN

Sonic hedgehog (SHH) is important for organogenesis during development. Recent studies have indicated that SHH is also involved in the proliferation and transformation of astrocytes to the reactive phenotype. However, the mechanisms underlying these are unknown. Involvement of SHH signaling in calcium (Ca) signaling has not been extensively studied. Here, we report that SHH and Smoothened agonist (SAG), an activator of the signaling receptor Smoothened (SMO) in the SHH pathway, activate Ca oscillations in cultured murine hippocampal astrocytes. The response was rapid, on a minute time scale, indicating a noncanonical pathway activity. Pertussis toxin blocked the SAG effect, indicating an involvement of a Gi coupled to SMO. Depletion of extracellular ATP by apyrase, an ATP-degrading enzyme, inhibited the SAG-mediated activation of Ca oscillations. These results indicate that SAG increases extracellular ATP levels by activating ATP release from astrocytes, resulting in Ca oscillation activation. We hypothesize that SHH activates SMO-coupled Gi in astrocytes, causing ATP release and activation of Gq/11-coupled P2 receptors on the same cell or surrounding astrocytes. Transcription factor activities are often modulated by Ca patterns; therefore, SHH signaling may trigger changes in astrocytes by activating Ca oscillations. This enhancement of Ca oscillations by SHH signaling may occur in astrocytes in the brain in vivo because we also observed it in hippocampal brain slices. In summary, SHH and SAG enhance Ca oscillations in hippocampal astrocytes, Gi mediates SAG-induced Ca oscillations downstream of SMO, and ATP-permeable channels may promote the ATP release that activates Ca oscillations in astrocytes.


Asunto(s)
Astrocitos/metabolismo , Señalización del Calcio , Proteínas Hedgehog/metabolismo , Hipocampo/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Proteínas Portadoras/metabolismo , Células Cultivadas , Hipocampo/citología , Ratones , Ratones Endogámicos ICR , Receptor Smoothened/metabolismo
7.
Biol Pharm Bull ; 42(3): 319-326, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30828062

RESUMEN

Ischemic stroke is one of the leading causes of severe disability and death. In clinical settings, tissue plasminogen activator (t-PA) for thrombolytic therapy is the only globally approved drug for the treatment of ischemic stroke. However, the proportion of patients who receive t-PA therapy is extremely limited due to its narrow therapeutic time window (TTW) and the risk of cerebral hemorrhage. Cerebral ischemia-reperfusion (I/R) injury is also a serious problem for patients' outcomes. Hence, the development of more effective therapies has been desired to prolong the TTW of t-PA and prevent cerebral I/R injury. For delivering drugs into the brain, the blood-brain barrier (BBB) must be overcome since it limits drug penetration into the brain, leading to insufficient therapeutic efficacy. As a distinctive pathology after an ischemic stroke, it was reported that the vascular permeability of the BBB is increased around the ischemic region. We found that nano-sized liposomes can pass through the disrupted BBB and accumulate in the I/R region, and that delivery of neuroprotective agents using a liposomal drug delivery system (DDS) is effective for the treatment of cerebral I/R injury. Moreover, we have recently demonstrated that combination therapy with liposomal drugs and t-PA can suppress the deleterious effects of t-PA and extend its TTW in a rat ischemic stroke model. These findings indicate that applications of nanoparticle DDS technology could be a hopeful approach to drug development for ischemic stroke therapy. In this review, we introduce our findings on ischemic stroke treatment using liposomal DDS and recent advances from other research groups.


Asunto(s)
Isquemia Encefálica/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Fármacos Neuroprotectores/administración & dosificación , Accidente Cerebrovascular/tratamiento farmacológico , Humanos , Liposomas , Fármacos Neuroprotectores/uso terapéutico
8.
J Stroke Cerebrovasc Dis ; 28(7): 2018-2025, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31047819

RESUMEN

PURPOSE: Previous studies have suggested that upper limb rehabilitation using therapeutic robots improves motor function of stroke patients. However, the effect of upper limb robotic rehabilitation on improving functioning in activities of daily living (ADL) remains unclear. The present study aimed to determine whether upper limb rehabilitation using single joint Hybrid Assistive Limb (HAL-SJ) affects ADL function and the use of a hemiparetic arm in ADLs of acute stroke patients. MATERIALS AND METHODS: Twelve acute stroke patients participated in the study and were randomly divided into group A or group B. The patients in group A followed an A-B-A-B design and those in group B followed a B-A-B-A design. The patients received combination HAL-SJ and occupational therapy during A and conventional occupational therapy during B. RESULTS: Upper limb motor function and ADLs, in particular, dressing the upper body, were improved during combination HAL-SJ and occupational therapy. Interestingly, the use of a hemiparetic arm in daily life evaluated using the motor activity log was also significantly improved during A in group A. CONCLUSIONS: Combination HAL-SJ and occupational therapy affects ADL function and real use of a hemiparetic arm in the daily life of acute stroke patients.


Asunto(s)
Actividades Cotidianas , Dispositivo Exoesqueleto , Actividad Motora , Terapia Ocupacional , Paresia/rehabilitación , Robótica/instrumentación , Rehabilitación de Accidente Cerebrovascular/instrumentación , Rehabilitación de Accidente Cerebrovascular/métodos , Accidente Cerebrovascular/terapia , Extremidad Superior/inervación , Adulto , Anciano , Terapia Combinada , Evaluación de la Discapacidad , Diseño de Equipo , Femenino , Humanos , Japón , Masculino , Persona de Mediana Edad , Paresia/diagnóstico , Paresia/fisiopatología , Recuperación de la Función , Accidente Cerebrovascular/diagnóstico , Accidente Cerebrovascular/fisiopatología , Factores de Tiempo , Resultado del Tratamiento
9.
Inorg Chem ; 57(11): 6648-6657, 2018 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-29790349

RESUMEN

We have investigated high-pressure, high-temperature phase transitions of spinel (Sp)-type MgV2O4, FeV2O4, and MnCr2O4. At 1200-1800 °C, MgV2O4 Sp decomposes at 4-7 GPa into a phase assemblage of MgO periclase + corundum (Cor)-type V2O3, and they react at 10-15 GPa to form a phase with a calcium titanite (CT)-type structure. FeV2O4 Sp transforms to CT-type FeV2O4 at 12 GPa via decomposition phases of FeO wüstite + Cor-type V2O3. MnCr2O4 Sp directly transforms to the calcium ferrite (CF)-structured phase at 10 GPa and 1000-1400 °C. Rietveld refinements of CT-type MgV2O4 and FeV2O4 and CF-type MnCr2O4 confirm that both the CT- and CF-type structures have frameworks formed by double chains of edge-shared B3+O6 octahedra (B3+ = V3+ and Cr3+) running parallel to one of orthorhombic cell axes. A relatively large A2+ cation (A2+ = Mg2+, Fe2+, and Mn2+) occupies a tunnel-shaped space formed by corner-sharing of four double chains. Effective coordination numbers calculated from eight neighboring oxygen-A2+ cation distances of CT-type MgV2O4 and FeV2O4 and CF-type MnCr2O4 are 5.50, 5.16, and 7.52, respectively. This implies that the CT- and CF-type structures practically have trigonal prism (six-coordinated) and bicapped trigonal prism (eight-coordinated) sites for the A2+ cations, respectively. A relationship between cation sizes of VIIIA2+ and VIB3+ and crystal structures (CF- and CT-types) of A2+B23+O4 is discussed using the above new data and available previous data of the postspinel phases. We found that CF-type A2+B23+O4 crystallize in wide ionic radius ranges of 0.9-1.4 Å for VIIIA2+ and 0.55-1.1 Å for VIB3+, whereas CT-type phases crystallize in very narrow ionic radius ranges of ∼0.9 Å for VIIIA2+ and 0.6-0.65 Å for VIB3+. This would be attributed to the fact that the tunnel space of CT-type structure is geometrically less flexible due to the smaller coordination number for A2+ cation than that of CF-type.

10.
Biol Pharm Bull ; 41(9): 1463-1470, 2018 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-29984736

RESUMEN

Upon differentiation of cells, remarkable changes in the structures of glycans linked to lipids on cell surface have been observed. Lactosylceramide (Lac-Cer) serves as a common precursor for a series of glycosphingolipids with diverse structures. In the present study, we examined the underlying mechanism for the biosynthesis of Lac-Cer upon differentiation of 3T3-L1 mouse preadipocytes to adipocytes. TLC analysis showed that the amounts of Lac-Cer decrease in 3T3-L1 adipocytes compared to 3T3-L1 preadipocytes. In accordance with this change, the gene expression level of ß4-galactosyltransferase (ß4GalT) 5, which was identified as Lac-Cer synthase, decreased drastically upon differentiation of 3T3-L1 preadipocytes. The analysis of the transcriptional mechanism of the ß4GalT5 gene demonstrated that the core promoter region is identified between nucleotides -299 and -1 relative to the translational start site. During adipocyte differentiation, the expression levels and promoter activities of the ß4GalT5 gene decreased dramatically. Since the Specificity protein 1 (Sp1)-binding sites in the promoter region were critical for the promoter activity, it is suggested that Sp1 plays an important role for the expression of the ß4GalT5 gene in 3T3-L1 cells. The gene and protein expression of Sp1 decreased significantly upon differentiation of 3T3-L1 preadipocytes. Taken together, the present study suggest that the expression of the ß4GalT5 gene decreases through reduced expression of the Sp1 gene and protein upon differentiation of 3T3-L1 peradipocytes to adipocytes, which may lead to the decreased amounts of Lac-Cer in 3T3-L1 adipocytes.


Asunto(s)
Adipocitos/enzimología , Diferenciación Celular/fisiología , Galactosiltransferasas/biosíntesis , Células 3T3-L1 , Animales , Galactosiltransferasas/genética , Expresión Génica , Ratones
11.
Biol Pharm Bull ; 40(8): 1282-1288, 2017 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-28529241

RESUMEN

Dramatic changes in the glycan structures of cell surface proteins have been observed upon malignant transformation of cells as induced by the altered expression levels of glycosyltransferases. Such changes are closely associated with the malignant properties of cancer cells. Transcription factor Sp1 regulates the gene expression of various molecules including glycosyltransferases. Herein, we investigated whether or not Sp1-downregulation affects to N-glycosylation of glycoproteins and malignant properties of A549 human lung cancer cell line. We established a stable clone whose Sp1-expression level was reduced to 50% of a control clone by RNA interference. Lectin blotting revealed that the ß4-galactosylation of highly branched N-glycans decreases mainly in cell adhesion molecule, E-cadherin. The analysis of underlying mechanism for decreased ß4-galactosylation of N-glycans showed that the gene expression level of ß4-galactosyltransferase (ß4GalT) 1 decreases dramatically by downregulation of Sp1 without changes in those of ß4GalT2 and N-acetylglucosaminyltransferase V. Mutations in the Sp1-binding sites of the ß4GalT1 gene promoter showed that the promoter activity decreases significantly, indicating that the gene expression is regulated by Sp1. These results indicate that the ß4-galactosylation of highly branched N-glycans decreases by downregulation of Sp1 through the reduced expression of the ß4GalT1 gene. Furthermore, the Sp1-downregulated cells showed the suppression of the anchorage-independent growth in soft agar and migratory activity when compared to the control cells. The present study demonstrates that downregulation of Sp1 suppresses the malignant properties of A549 cells through the decreased ß4-galactosylation of highly branched N-glycans.


Asunto(s)
Cadherinas/metabolismo , Galactosiltransferasas/genética , Polisacáridos/metabolismo , Regiones Promotoras Genéticas/genética , Factor de Transcripción Sp1/metabolismo , Células A549 , Antígenos CD , Sitios de Unión/genética , Regulación hacia Abajo , Galactosiltransferasas/metabolismo , Regulación Neoplásica de la Expresión Génica , Glicosilación , Humanos , Neoplasias Pulmonares/genética , Mutación , N-Acetilglucosaminiltransferasas/genética , N-Acetilglucosaminiltransferasas/metabolismo , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Factor de Transcripción Sp1/genética
12.
Endocr J ; 64(3): 255-268, 2017 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-27980238

RESUMEN

In skeletal muscle, sortilin plays a predominant role in the sorting of glucose transporter 4 (Glut4), thereby controlling glucose uptake. Moreover, our previous study suggested that the sortilin expression levels are also implicated in myogenesis. Despite the importance of sortilin in skeletal muscle, however, the regulation of sortilin expression has not been completely understood. In the present study, we analyzed if the sortilin expression is regulated by glucose in C2C12 myocytes and rat skeletal muscles in vivo. Sortilin protein expression was elevated upon C2C12 cell differentiation and was further enhanced in the presence of a high concentration of glucose. The gene expression and protein degradation of sortilin were not affected by glucose. On the other hand, rapamycin partially reduced sortilin induction by a high concentration of glucose, which suggested that sortilin translation could be regulated by glucose, at least in part. We also examined if the sortilin regulation by glucose was also observed in skeletal muscles that were obtained from fed or fasted rats. Sortilin expression in both gastrocnemius and extensor digitorum longus (EDL) muscle was significantly decreased by 17-18h of starvation. On the other hand, pathological levels of high blood glucose did not alter the sortilin expression in rat skeletal muscle. Overall, the present study suggests that sortilin protein levels are reduced under hypoglycemic conditions by post-transcriptional control in skeletal muscles.


Asunto(s)
Proteínas Adaptadoras del Transporte Vesicular/metabolismo , Glucemia/análisis , Diabetes Mellitus Experimental/metabolismo , Regulación hacia Abajo , Ayuno/metabolismo , Músculo Esquelético/metabolismo , Proteínas Adaptadoras del Transporte Vesicular/agonistas , Proteínas Adaptadoras del Transporte Vesicular/genética , Animales , Diferenciación Celular , Línea Celular , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/patología , Regulación hacia Abajo/efectos de los fármacos , Privación de Alimentos , Glucosa/metabolismo , Miembro Posterior , Masculino , Diana Mecanicista del Complejo 1 de la Rapamicina , Complejos Multiproteicos/antagonistas & inhibidores , Complejos Multiproteicos/metabolismo , Células Musculares/citología , Células Musculares/efectos de los fármacos , Células Musculares/metabolismo , Células Musculares/patología , Músculo Esquelético/citología , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Inhibidores de Proteínas Quinasas/farmacología , ARN Mensajero/metabolismo , Ratas Wistar , Sirolimus/farmacología , Serina-Treonina Quinasas TOR/antagonistas & inhibidores , Serina-Treonina Quinasas TOR/metabolismo , Regulación hacia Arriba/efectos de los fármacos
15.
FASEB J ; 27(4): 1362-70, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23241312

RESUMEN

FK506 (Tacrolimus) has the potential to decrease cerebral ischemia-reperfusion injury. However, the clinical trial of FK506 as a neuroprotectant failed due to adverse side effects. This present study aimed to conduct the selective delivery of FK506 to damaged regions, while at the same time reducing the dosage of FK506, by using a liposomal drug delivery system. First, the cytoprotective effect of polyethylene glycol-modified liposomes encapsulating FK506 (FK506-liposomes) on neuron-like pheochromocytoma PC12 cells was examined. FK506-liposomes protected these cells from H2O2-induced toxicity in a dose-dependent manner. Next, we investigated the usefulness of FK506-liposomes in transient middle cerebral artery occlusion (t-MCAO) rats. FK506-liposomes accumulated in the brain parenchyma by passing through the disrupted blood-brain barrier at an early stage after reperfusion had been initiated. Histological analysis showed that FK506-liposomes strongly suppressed neutrophil invasion and apoptotic cell death, events that lead to a poor stroke outcome. Corresponding to these results, a single injection of FK506-liposomes at a low dosage significantly reduced cerebral cell death and ameliorated motor function deficits in t-MCAO rats. These results suggest that liposomalization of FK506 could reduce the administration dose by enhancing the therapeutic efficacy; hence, FK506-liposomes should be a promising neuroprotectant after cerebral stroke.


Asunto(s)
Fármacos Neuroprotectores/farmacología , Daño por Reperfusión/tratamiento farmacológico , Tacrolimus/farmacología , Animales , Células Cultivadas , Peróxido de Hidrógeno/metabolismo , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Ataque Isquémico Transitorio/tratamiento farmacológico , Liposomas/metabolismo , Masculino , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Ratas , Ratas Wistar
16.
Artif Organs ; 38(8): 662-6, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25295359

RESUMEN

Aliposomal drug delivery system was previously applied to ischemic brain model rats for the treatment of brain ischemia, and we observed that 100-nm-sized liposomes could extravasate and accumulate in the ischemic brain region even when cerebral blood flow was markedly reduced in permanent middle cerebral artery occlusion (p-MCAO) model rats. In the present study, we investigated the real-time cerebral distribution of polyethylene glycol (PEG)-modified liposomes (PEGliposomes) labeled with 1-[18F]fluoro-3,6-dioxatetracosane in p-MCAO rats by positron emission tomography (PET). [18F]-Labeled PEG-liposomes were intravenously injected into p-MCAO rats 1 h after the onset of occlusion, and then a PET scan was performed for 2 h. The PET scan showed that the signal intensity of [18F] gradually increased in the ischemic region despite the drastic reduction in cerebral perfusion, suggesting that PEG-liposomes had accumulated in and around the ischemic region. Therefore,drug delivery to the ischemic region by use of liposomes would be possible under ischemic conditions, and a liposomal drug delivery system could be a promising strategy for protecting the ischemic brain from damage before recovery from ischemia.


Asunto(s)
Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Liposomas/farmacocinética , Polietilenglicoles/farmacocinética , Animales , Modelos Animales de Enfermedad , Sistemas de Liberación de Medicamentos , Infarto de la Arteria Cerebral Media/diagnóstico por imagen , Infarto de la Arteria Cerebral Media/metabolismo , Liposomas/uso terapéutico , Masculino , Polietilenglicoles/uso terapéutico , Tomografía de Emisión de Positrones , Ratas , Ratas Wistar
17.
Commun Chem ; 7(1): 189, 2024 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-39191879

RESUMEN

Post-spinel-type AB2O4 compounds are stable at higher pressures than spinel phases. These compounds have garnered much interest in geo- and materials science for their geochemical importance as well as potential application as high ionic conductors and materials with strongly correlated electrons. Here, large-volume high-pressure syntheses, structural features and properties of post-spinels are reviewed. Prospects are discussed for future searches for post-spinel-type phases by applying advanced large-volume high-pressure technology.

18.
Biochem Biophys Res Commun ; 430(4): 1201-5, 2013 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-23268342

RESUMEN

The use of a liposomal drug delivery system is a promising strategy for avoiding side effects and enhancing drug efficiency by changing the distribution of the intact drug. We have previously shown that liposomal agents quickly accumulated in an ischemia-reperfusion region and ameliorated cerebral ischemia-reperfusion injury when they were injected after reperfusion in transient middle cerebral artery occlusion (t-MCAO) rats. In the present study, we hypothesized that liposomes also act effectively as a drug carrier in the ischemic state, since the integrity of the blood brain barrier is disrupted at an early stage after an ischemic event. To test this hypothesis, the cerebral distribution of fluorescence-labeled liposomes was observed in permanent MCAO (p-MCAO) rats. The liposomes accumulated in the ischemic core and the penumbra region when injected at 1 or 2h after occlusion. The accumulation in the ischemic core region was clearly greater than that in the penumbra region, despite the cerebral blood perfusion of the core region being substantially reduced. This result suggests that drug delivery to an ischemic region using liposomes is possible even when cerebral blood circulation has not recovered. Because liposomal drug delivery systems have the potential to effectively employ a number of agents that have failed in clinical trials, they may offer an effective strategy for achieving neuroprotection in stroke patients.


Asunto(s)
Isquemia Encefálica/metabolismo , Corteza Cerebral/irrigación sanguínea , Corteza Cerebral/metabolismo , Infarto de la Arteria Cerebral Media/metabolismo , Nanopartículas , Animales , Isquemia Encefálica/tratamiento farmacológico , Modelos Animales de Enfermedad , Sistemas de Liberación de Medicamentos , Liposomas/metabolismo , Masculino , Fármacos Neuroprotectores/administración & dosificación , Fármacos Neuroprotectores/farmacocinética , Tamaño de la Partícula , Perfusión , Ratas , Ratas Wistar , Flujo Sanguíneo Regional , Daño por Reperfusión/metabolismo
19.
Biol Pharm Bull ; 36(2): 287-91, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23370357

RESUMEN

Novel polycation liposomes decorated with cyclic(Cys-Arg-Gly-Asp-D-Phe) peptide (cyclicRGD)-polyethylene glycol (PEG) (RGD-PEG-polycation liposomes (PCL)) were previously developed for cancer therapy based on RNA interference. Here, we demonstrate the in vivo delivery of small interfering RNA (siRNA) to tumors by use of RGD-PEG-PCL in B16F10 melanoma-bearing mice. Pharmacokinetic data obtained by positron emission tomography showed that cholesterol-conjugated siRNA formulated in RGD-PEG-PCL markedly accumulated in the tumors. Delivered by RGD-PEG-PCL, a therapeutic cocktail of siRNAs composed of cholesterol-conjugated siRNAs for c-myc, MDM2, and vascular endothelial growth factor (VEGF) were able to significantly inhibit the growth of B16F10 melanoma both in vitro and in vivo. These data suggest that targeted delivery of siRNAs by use of RGD-PEG-PCL has considerable potential for cancer treatment.


Asunto(s)
Neoplasias Pulmonares/terapia , Melanoma Experimental/terapia , Proteínas Proto-Oncogénicas c-mdm2/genética , ARN Interferente Pequeño/administración & dosificación , alfa-Amilasas Salivales/genética , Factor A de Crecimiento Endotelial Vascular/genética , Animales , Proliferación Celular/efectos de los fármacos , Etilenodiaminas/química , Liposomas , Pulmón/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Organofosfatos/química , Péptidos Cíclicos/química , Polietilenglicoles/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA